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We report the autopsy ﬁ  ndings for a 45-year-old man 
with polyradiculoneuropathy and fatal acute disseminated 
encephalomyelitis after having Mycoplasma pneumoniae 
pneumonia. M. pneumoniae antigens were demonstrated by 
immunohistochemical analysis of brain tissue, indicating neu-
roinvasion as an additional pathogenetic mechanism in cen-
tral neurologic complications of M. pneumoniae infection.
A 
45-year-old, previously healthy man had fever, pain in 
the extremities, nasal discharge, and cough with non-
purulent sputum. He sought clinical care 1 week after onset 
of illness because of his deteriorating general state, includ-
ing a headache and paresthesias in both hands. Bilateral 
basal pneumonia was diagnosed and treated with clarithro-
mycin. During the ensuing 4 days, a rapidly ascending 
polyradiculoneuropathy resulted in tetraparesis, followed 
by facial palsy, ophthalmoplegia, and then paralysis of all 
cranial nerves. The initially fully alert patient became co-
matose, and assisted respiration was necessary.
On day 9 of the patient’s illness, an ELISA (Gen-
zyme Diagnostics Virotech, Rüsselsheim, Germany) was 
performed on serum samples and showed a Mycoplasma 
pneumoniae immunoglobulin (Ig) G antibody titer of 28.2 
Virotech-units/mL (VE) (cut-off 9.0–11.0) and an IgM an-
tibody titer of 20.9 VE (cut-off 9.0–11.0). A PCR for M. 
pneumoniae was positive in tracheobronchial secretions on 
day 12, and complement ﬁ  xation test (antigen purchased 
from Virion CH-8803 Rüschlikon, Zürich, Switzerland) 
showed M. pneumoniae antibody titers of 1,280 (serum) 
and 4 (cerebrospinal ﬂ  uid) on day 16.
Serologic tests for cytomegalovirus, Epstein-Barr vi-
rus, HIV, measles virus, mumps virus, spring-summer en-
cephalitis virus, Borrelia burgdorferi, Brucella spp., Legio-
nella spp., Treponema pallidum, and Toxoplasma gondii 
were negative. No herpes simplex virus 1 or 2 was detected 
by PCR in cerebrospinal ﬂ  uid, and PCR results were also 
negative for Chlamydia pneumoniae in tracheobronchial 
secretions.
On day 8, cerebrospinal ﬂ  uid examinations showed 
a total cell count of 43/mm3 (89% granulocytes and 11% 
mononuclear cells), total protein 1.3 g/L, and glucose 4.3 
mmol/L. On day 15, when the patient was comatose, a 
total cell count of 794/mm3 (84% granulocytes and 16% 
mononuclear cells), total protein 4.6 g/L, and glucose 1.5 
mmol/L. Blood values showed leucocytosis with neutro-
philia and mild thrombocytosis of 480 g/L.
A computed tomographic scan on day 15 showed brain 
edema and multiple inﬂ  ammatory/demyelination  lesions 
in the subcortical white matter of both hemispheres and 
within the brain thalami, capsulae internae, midbrain, and 
pons. Electroneurographic and myographic results showed 
a severe form of a peripheral axonal neuropathy. No anti-
gangliosid (GM) 1 or anti-GM2 antibodies were found in 
the patient’s serum on day 12. We did not look for GQ1b 
antibodies.
The clinical diagnosis was polyradiculoneuropathy 
(atypical Guillain-Barré syndrome) and acute encephali-
tis as complications of bilateral pneumonia caused by M. 
pneumoniae. In addition to clarithromycin, the patient re-
ceived amoxicillin and ceftriaxone and was given Ig (0.4 g/
kg bodyweight/day for 5 days). He died of intractable cere-
bral edema on day 17 of illness, 10 days after the onset of 
neurologic symptoms.
At autopsy, the brain was edematous, weighing 1,560 g.
The cerebral meninges were macroscopically unconspicu-
ous. On sectioning, multiple hemorrhagic foci with diame-
ters from 0.5 mm to 2 mm were seen within the white matter 
of the cerebral and cerebellar hemispheres, the brainstem, 
and also sparsely within the cortex and basal ganglia. There 
were mild bilateral basal bronchopneumonia and mild 
hepatic steatosis.
Microscopically, most of the hemorrhagic foci in the 
brain consisted of ﬁ  brinoid necrosis of the wall of small 
veins, surrounded by hemorrhagic parenchymal necro-
sis and a dense annular inﬁ  ltrate of neutrophils and mac-
rophages (Figure). In less disease-advanced areas, zones 
of acute perivascular periaxial demyelination were seen 
around intact vessels; within these same areas, a few ves-
sels were associated with a sleevelike inﬁ  ltrate of T lym-
phocytes and macrophages with no evidence of demyeli-
nation or necrosis, which probably represented an earlier 
stage of the process.
Multiple levels of the spinal cord had undergone near 
total necrosis, extending focally into the spinal nerve roots. 
Perivascular lesions, as observed in the brain, were also 
present, albeit in smaller numbers. The spinal meninges 
were focally occupied by a granulocytic inﬁ  ltrate. Many 
meningeal vessels were occluded by fresh thrombi. Tissue 
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spinal ganglia, sciatic nerve, and brachial plexus showed 
acute widespread demyelination, with a dense inﬁ  ltrate of 
CD68-positive macrophages and a mild perivascular inﬁ  l-
trate of T lymphocytes and plasma cells.
Immunohistochemical assays were performed by us-
ing a polyclonal antibody (Centers for Disease Control 
and Prevention, Atlanta, GA, USA), an IgG1 kappa mono-
clonal anti-M. pneumoniae antibody (U.S. Biological, 
Swampscott, MA, USA; cat. no. M9750–12; dilution 1:25), 
and an immunoalkaline phosphatase with naphthol fast red 
chromogenic substrate. M. pneumoniae antigens were ob-
served inside macrophages present in the inﬂ  ammatory 
inﬁ  ltrate surrounding necrotic vessels within the cerebral 
hemispheres (including a biopsy specimen obtained 1 day 
before death), medulla oblongata, and spinal cord (Figure). 
No M. pneumoniae antigens were found in tissue samples 
of sciatic nerve and lung, probably because of antigen 
clearance with time, higher drug levels outside the central 
nervous system (CNS) as an effect of the blood brain bar-
rier, or both. Anatomic diagnoses were acute disseminated 
encephalomyelitis; acute, inﬂ  ammatory,  demyelinating 
polyradiculoneuropathy; necrosis of the spinal cord; brain 
edema; and disseminated intravascular coagulation.
Neurologic disease is a well-known extrapulmonary 
complication of M. pneumoniae infection (1,2), manifest-
ing as meningoencephalitis, cerebellar ataxia (3), brain-
stem disease (4), transverse myelitis (5), polyradiculitis 
(4,6), or cranial nerve palsies (4,6). Our ﬁ  ndings and previ-
ous anatomopathologic reports (4,6–8) support the gener-
ally held view that central neurologic complications are the 
result of disseminated acute encephalomyelitis (ADEM) 
or of Hurst syndrome, regarded as a hyperacute variant of 
ADEM. Congestion and edema of the brain, widespread 
perivenous demyelination mainly in the cerebral and cer-
ebellar white matter, basal ganglia, brainstem, and spinal 
cord, and in severe cases, necrosis of vessels and perivas-
cular tissue are the histologic characteristics. Rarely, the 
demyelinating process extends into spinal nerve roots and 
peripheral nerves.
The pathogenesis of this syndrome is not fully eluci-
dated. An infection-induced, autoimmune hypersensitivity 
reaction to myelin proteins is the most frequently advanced 
hypothesis, suggested by the morphologic similarity to ex-
perimental allergic encephalitis and the interval between 
onset of infection and beginning of neurologic symptoms. 
A T-cell–mediated, delayed type, hypersensitivity reaction, 
possibly accompanied by an immune-complex type vascu-
litis (4), seems most probable. The occasional demonstra-
tion of circulating antibodies against neural tissue supports 
this hypothesis. Necrosis of the spinal cord found at autop-
sy in our patient was probably due to secondary ischemia 
caused by edema and vascular thrombosis, and a similar 
process may be responsible for the permanent paraplegia 
of other reported patients with transverse myelitis after M. 
pneumoniae infection (5,6).
In recent years, the additional or alternative role of 
invasion of the CNS by the organism itself has gained re-
newed interest. M. pneumoniae RNA can be detected in 
brain tissue by nucleic acid hybridization (8), and the pres-
ence of the organism was demonstrated in cerebrospinal 
ﬂ  uid by PCR (1,9–12) and by culture (3,12). As shown in 
our case, the microbial antigens can be immunohistochemi-
cally detected in histopathologically involved areas of the 
CNS, both in brain biopsy specimens and at autopsy.
Narita et al. searched for M. pneumoniae by PCR in 
the cerebrospinal ﬂ  uid of 32 patients; all were <15 years 
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Figure. A) Subcortical cerebral white matter with numerous 
perivascular foci of demyelination and necrosis (hematoxylin and 
eosin stain, original magniﬁ  cation ×40). B) Immunohistochemical 
evidence of Mycoplasma pneumoniae antigen inside 
macrophages present in the perivascular inﬂ  ammatory  inﬁ  ltrate 
(immunohistochemical assay performed by using the monoclonal 
anti–M. pneumoniae antibody and naphthol fast red as counterstain, 
original magniﬁ  cation ×50).Acute Disseminated Encephalomyelitis
and had meningitis, encephalitis, or meningoencephalitis 
after M. pneumoniae infection. Positive results were found 
in 16 of 32 patients. Of the 16 positive results, 15 were seen 
in samples from 23 patients who had neurologic compli-
cations within 7 days after onset of infection, whereas the 
search was positive in only 1 of the 9 remaining patients 
with late onset of neurologic complications (11,13). Bitnun 
et al. draw a similar conclusion in their review of childhood 
encephalitis and M. pneumoniae, stating that “direct inva-
sion of the CNS is the probable pathogenetic mechanism in 
children with a brief (<5 days) duration of the prodromal 
illness” (9). In our patient, neurologic symptoms started 7 
days after onset of illness.
The organism is likely present, at least in some patients, 
in the CNS of those who have early onset of neurologic 
complications. To assess its pathogenetic role is difﬁ  cult. 
The organism may either cause direct damage or trigger a 
more violent immunologic reaction. Treatment should in 
that case aim at arriving rapidly at a sufﬁ  cient concentra-
tion of effective antimicrobial agents within the CNS. The 
fact that neuroinvasion is more prevalent in patients who 
have an early onset neurologic complications may also re-
late to necrosis of vessels, a feature of rapidly progressing 
disease, which may be caused by or facilitate microbial in-
vasion. Prevention, diagnosis, and treatment of neurologic 
complications in mycoplasmal infections still pose many 
problems. Immunohistochemistry may contribute to a bet-
ter understanding of the pathogenesis of the disease and 
provide insights on clinical management of patients.
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